Table 1. Prognostic exosome genes in TCGA-TNBC.

From: Implication of an exosome-based gene signature for estimating clinical outcomes of triple-negative breast cancer and assisting in individualized therapy

Exosome gene

Hazard ratio

Lower 95% CI

Upper 95% CI

P

ALAD

1.872656

1.13417

3.091986

0.014204

LIMA1

1.579637

1.041728

2.395301

0.031364

ARF1

0.645698

0.433548

0.961661

0.031372

VWF

1.59856

1.02825

2.48519

0.037187

STXBP1

1.579751

1.049228

2.378524

0.028515

VAMP3

1.753917

1.068976

2.87773

0.026149

PGK1

1.881192

1.094098

3.234519

0.022302

PSAT1

0.618873

0.412299

0.928948

0.020578

PTGR1

2.310661

1.388034

3.846559

0.001278

H3F3A

0.437266

0.266667

0.717005

0.001044

CFH

1.725604

1.008467

2.952709

0.046511

CPA3

1.64482

1.087531

2.487682

0.018399

EPCAM

0.629729

0.452308

0.876745

0.006162

GNB2

1.712444

1.02981

2.847577

0.038156

EPHB2

1.668638

1.063232

2.618764

0.025974

NANS

2.321308

1.259173

4.279375

0.006967

SMPDL3B

0.553857

0.358558

0.855533

0.007738

LFNG

1.590792

1.07307

2.358298

0.02083

PHGDH

0.597175

0.372157

0.958244

0.032619

BPI

0.399459

0.182605

0.87384

0.021583

FAM129B

3.095356

1.7385

5.511206

0.000124

HPGD

1.565302

1.069887

2.29012

0.021004

KRT15

0.632451

0.401302

0.996741

0.048379

THY1

2.01975

1.20041

3.39833

0.008096

ALCAM

1.556625

1.005831

2.409034

0.047027

KRT6A

1.816517

1.190498

2.771726

0.005627

SERPINE1

1.790161

1.158129

2.767114

0.008776

Back to article page